Article
STAT1 Drives Tumor Progression in Serous Papillary Endometrial Cancer
29 Sept 2014
Abstract excerpt
Recent studies of the interferon-induced transcription factor STAT1 have associated its dysregulation with poor prognosis in some cancers, but its mechanistic contributions are not well defined. In this study, we report that the STAT1 pathway is constitutively upregulated in type II endometrial cancers. STAT1 pathway alteration was especially prominent in serous papillary endometrial cancers (SPEC) that are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
